The relationship of treatment modality in alopecia areata with life quality, anxiety, and depression; [Alopesi areatada tedavi yöntemi ile yaşam kalitesi, anksiyete ve depresyon ilişkisi]
No Thumbnail Available
Date
2018
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Objective: Alopecia areata is a recurrent nonscarring type of hair loss that can affect any hair-bearing area. This study aims to evaluate the anxiety and depression risks of patients diagnosed with alopecia areata, by using Dermatology Quality of Life Index (DLQI), Short Form-36 (SF-36), and Hospital Anxiety Depression scales. Material and Methods: Patients with a diagnosis of alopecia areata, alopecia totalis and alopecia universalis who were admitted to Celal Bayar University Medical Faculty and Cerrahpasa University Medical Faculty, Dermatology outpatient clinics, were included in the study. Patients with a co-existing dermatological or psychiatric disease were excluded. 72 patients between the ages of 18 and 60 years were included in the study. Results: DLQI scores of the patients at the beginning and at the end of six-month therapy were compared and an overall statistically insignificant decrease was observed, particularly in the systemic treatment groups. At the end of six months, average SF-36 scores increased, pointing an improvement in quality of life. At the end of six months anxiety scores also decreased, especially for the patients receiving systemic treatment (p=0,055). Conclusion: The treatment choices and effectivities for diseases such as alopecia areata is limited. Thus therapy success should not only be based on the clinical outcome, but also on the changes of quality of life indexes and depression/anxiety scores, which are also important on the prognosis of the disease. © 2018 by Türkiye Klinikleri.
Description
Keywords
adult , alopecia areata , alopecia totalis , alopecia universalis , anxiety , anxiety disorder , Article , clinical outcome , depression , Dermatology Life Quality Index , female , Hospital Anxiety and Depression Scale , human , major clinical study , male , prognosis , quality of life , scoring system , Short Form 36 , systemic therapy